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Evolutionary Forces Shape the Human RFPL1,2,3 Genes
toward a Role in Neocortex Development
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Silvia Sorce,1 Te´re`se Laforge,1 Laetitia Aubry,3 Philipp Khaitovich,4 Marc Peschanski,3
Stylianos E. Antonarakis,2 and Karl-Heinz Krause1
The size and organization of the brain neocortex has dramatically changed during primate evolution. This is probably due to the emer-
gence of novel genes after duplication events, evolutionary changes in gene expression, and/or acceleration in protein evolution. Here,
we describe a human Ret ﬁnger protein-like (hRFPL)1,2,3 gene cluster on chromosome 22, which is transactivated by the corticogenic tran-
scription factor Pax6. High hRFPL1,2,3 transcript levels were detected at the onset of neurogenesis in differentiating human embryonic
stem cells and in the developing human neocortex, whereas the unique murine RFPL gene is expressed in liver but not in neural tissue.
Study of the evolutionary history of the RFPL gene family revealed that the RFPL1,2,3 gene ancestor emerged after the Euarchonta-Glires
split. Subsequent duplication events led to the presence of multiple RFPL1,2,3 genes in Catarrhini (~34 mya) resulting in an increase in
gene copy number in the hominoid lineage. In Catarrhini, RFPL1,2,3 expression proﬁle diverged toward the neocortex and cerebellum
over the liver. Importantly, humans showed a striking increase in cortical RFPL1,2,3 expression in comparison to their cerebellum, and to
chimpanzee and macaque neocortex. Acceleration in RFPL-protein evolution was also observed with signs of positive selection in the
RFPL1,2,3 cluster and two neofunctionalization events (acquisition of a speciﬁc RFPL-Deﬁning Motif in all RFPLs and of a N-terminal
29 amino-acid sequence in catarrhinian RFPL1,2,3). Thus, we propose that the recent emergence and multiplication of the RFPL1,2,3
genes contribute to changes in primate neocortex size and/or organization.Introduction
The neocortex, which is the most recent brain structure,
emerged with mammals approximately 200 million years
ago (mya) and increased in size in many branches of mam-
malian evolution, mostly in the lineage of anthropoid
primates.1 With the emergence of the Homo genus (~2.5–
3 mya), acceleration in cortical enlargement occurred,
especially over the last two million years in which the total
brain size went from 500–800 cm3 (Homo habilis) to 1200–
1400 cm3 (Homo sapiens). Together with the size increase,
transformations in the organization of the brain occurred
as the two cerebral hemispheres developed specializations
that led to the emergence of speciﬁc behavioral traits in
human, such as the development of complex languages
or tools, self-awareness, and cultures.2
At a developmental level, the generation of the cortical
cells is triggered by modiﬁcations in cell-cycle kinetics of
the neural progenitors leading to their differentiation.3 It
has been reported that the cell-cycle parameters of the pro-
genitors evolved in primates increasing the number of
cortical cells produced;4 such an increase contributes to
changes in neocortex development.3,5,6 However, the
genetic basis of primate brain evolution remains obscure.
Genome-wide approaches comparing human to other
primates revealed that humans present an expansion in
the copy number of genes involved in brain structureand/or function7 and an increase in gene expression in
the neocortex.8,9 Furthermore, genes involved in brain
development show higher rates of protein evolution in
the primate lineage leading to human.10 The latter has
been particularly documented for the cell-cycle regulating
MCPH gene family (MIM 251200), which are the only
genes known to date to determine brain size.11–13
The transcription factor Pax6 controls the speciﬁcation
of neural progenitors during corticogenesis.14,15 In mouse,
PAX6-deﬁcient cortical progenitors show during neurogen-
esis a shorter cell-cycle duration that impairs their differen-
tiation,16–18 and in human, heterozygous PAX6 mutation
leads to cognitive impairments by altering cortical region-
alization.19 However, the molecular mechanisms involved
in Pax6-mediated corticogenesis are largely unknown.
Interestingly, they could differ between species. Although
Pax6 is found in neural progenitors of the ventricular
and subventricular zones common to rodents and
primates, its expression has also been detected in a large
population of primate-speciﬁc neural progenitors located
in the outer subventricular zone.6,20 Furthermore, different
Pax6 binding sites have been identiﬁed in rodents and
human, suggesting that Pax6 transactivates different
gene networks in those species.21
In an effort to identify genes involved in neocortex
evolution we set out to (1) identify new Pax6 target genes
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evolutionary behavior of those genes. We identiﬁed the
human Ret-ﬁnger protein-like (hRFPL)1,2,3 genes as Pax6
targets and observed that they were highly expressed in
human embryonic stem cell-derived neurogenesis and in
human fetal neocortex. Evolutionary analyses and expres-
sion proﬁling of the RFPL1,2,3 genes indicated that they
showed signs of positive selection, an increase in gene
copy number in the hominoid lineage, and a striking
increase in cortical expression in human in comparison
to chimpanzee and macaque.
Material and Methods
Cell Culture
Human HeLa-TAT cell lines were obtained from the National Insti-
tutes of Health AIDS Research and Reference Reagent; HEK293T
cells were kindly provided by Dr. P. Salmon (Department of Funda-
mental Neurosciences, University of Geneva, Switzerland). Cells
were cultured at 37C with 5% CO2 in DMEM medium supple-
mented with 10% fetal-bovine serum, penicillin and streptomycin
(all from GIBCO-Invitrogen). SA-01 human embryonic stem cells
(Cellartis AB) weremaintained on a layer of mitotically inactivated
STO feeder cells. They were cultured in DMEM/F12 Glutamax
supplemented with 20% knockout serum replacement, 1 mM
nonessential amino acids, penicillin and streptomycin, 0.55 mM
b-mercaptoethanol (all from GIBCO-Invitrogen), and 10 ng/ml
recombinant human FGF2 (Invitrogen). Cultures were fed daily
and manually passed every 5–7 days.
Neuronal Differentiation of Human Embryonic
Stem Cells
Induction of neural progenitors and neuronal differentiation of
SA-01 human embryonic stem cells were performed according to
Perrier et al.,22 with slight modiﬁcations. In brief, the cells were
plated on mitotically inactivated murine bone-marrow-derived
stromal feeder MS5 cells in serum replacement (KSR) medium
containing DMEM/F12 supplemented with 15% knockout serum
replacement, 1 mM nonessential amino acids, penicillin/strepto-
mycin, and 0.55 mM b-mercaptoethanol (all from GIBCO-Invitro-
gen). After 12 days in these conditions, KSR medium was replaced
by N2 medium (DMEM/F12 supplemented with 25 mg/ml insulin,
50 mg/ml transferrin, 100 mMputrescine, 30 nM selenium chloride,
20 nM progesterone [all from GIBCO-Invitrogen], penicillin and
streptomycin). Medium was changed every 2–3 days, and growth
factors were added. At day 24 of differentiation, rosette structures
were mechanically collected and transferred to 15 mg/ml polyorni-
thine- and 1 mg/ml laminin-coated culture dishes in N2 medium
supplemented with growth factors. After 8–12 days, cells were
exposed to Mg2þ-free Hanks’ Balanced Salt Solution for 3 hr at
37C, spun at 500 3 g for 5 min, resuspended in N2 medium, and
plated onto polyornithine- and laminin-coated culture dishes
(105 cells per cm2). After two other passages in the same conditions,
we differentiated the cells by replating them onto polyornithine-
and-laminin-coated culture dishes (25 to 503 103 cells per cm2).
Microarray Transcriptome Analysis
Two days after transduction of HeLa cells with GFP or PAX6, total
RNA from each sample was isolated, labeled, and hybridized to
Affymetrix oligonucleotide-array-containing probes to 38,500
human genes. Total RNA was isolated from HeLa cells with Qiash-The Amredder kit (QIAGEN) and puriﬁed with QIAGEN RNeasy kit in
accordance with the ‘‘RNA cleanup’’ protocol. All RNAs were of
high and comparable quality as determined with the 2100 Bioana-
lyzer (Agilent Technologies). Biotinylation of 10 mg RNA, hybrid-
ization to Affymetrix Human Genome U133 Plus 2.0 arrays,
washing steps, and array scanning were carried out in accordance
with Affymetrix protocols. Expression data were analyzed with
GeneSpring GX 7 (Agilent Technologies). Arrays were scaled to
the same average intensity with all probes on the array.
Real-Time Quantitative PCR
Total RNA from human embryonic stem cells was isolated with
RNeasy Mini kit according to the manufacturer’s instructions
(QIAGEN). We removed residual genomic DNA by incubating
the RNA solution with 30 u RNase-free DNase for 15 min at
room temperature with RNase-Free DNase Set (QIAGEN). Human
fetal brain total RNAs were obtained from Biochain Institute. Total
RNA (1 mg) was reverse transcribed with the Superscript II kit
according to the manufacturer’s instructions (Invitrogen). Real-
time PCR reactions were performed with a Power SYBR Green
PCR Master Mix (Applied Biosystems) and a Chromo 4TM Real-
Time system (Bio-Rad). The ampliﬁcation efﬁciency of each pair
of primers was determined by comparison with a standard curve
generated with serially diluted cDNA of fetal brain. Quantiﬁcation
was performed at a threshold detection line (CT value). The CT of
each target genes was normalized against that of the housekeeping
genes, cyclophilin or eEF1A1. The 2–DDCT method was used to de-
termine the relative level of expression of each gene.23 cDNAs
from fetal or adult brain and adult testis were used as calibrators.
The list of the primers used is given in Table S1, available online.
Immunocytochemistry
Three days after transduction, cells were washed in PBS and ﬁxed
with 2% paraformaldehyde (w/v) for 30 min at room temperature.
After two washes in PBS/0.05% Tween-20 buffer, cells were per-
meabilized in PBS containing 0.5% (v/v) Triton X-100 for 30
min at room temperature and washed twice more in PBS/0.05%
Tween-20 buffer. The ﬁxed cells were then treated with PBS con-
taining 1% fetal-calf serum (blocking buffer) for 30 min and incu-
bated with Pax6 (1:100, Santa Cruz Biotechnology) and
hRFPL1,2,3 (1:100, Abnova) primary antibodies for 1 hr at room
temperature. After two washes in blocking buffer, cells were incu-
bated with the secondary antibodies (Alexa Fluor 488 or 555
conjugates, 1:1000, Molecular Probes) for 1 hr at room tempera-
ture. The cells were ﬁnally washed twice in PBS/0.05% Tween-20
buffer, once in PBS buffer and once in distilled water before
mounting with Fluorsave (Calbiochem). Visualization analysis
was performed with an AxioSkop 2 Plus microscope equipped
for epiﬂuorescence and recorded with an AxioCam HR CCD
camera and the AxioVision 4 software (Zeiss).
Chromatin-Immunoprecipitation Assay
We treated HeLa cells for 8 min at room temperature 48 hr after
transduction with GFP or PAX6 by adding to the culture medium
5mMHEPES (pH7.9), containing10mMNaCl and1.1% formalde-
hyde. Fixationwas stoppedby anadditionof 180mMglycine.After
one wash with PBS, we lyzed the cells by pipetting them up and
down in ice-cold 10 mM Tris-HCl (pH 8.0), 0.5% NP-40 supple-
mented with complete protease inhibitor (Roche). Nuclei were
pelleted and lyzed in 10 mM Tris-HCl (pH 8.0), 500 mMNaCl, 1%
Triton X-100, and 0.5% sodium deoxycholate supplemented witherican Journal of Human Genetics 83, 208–218, August 8, 2008 209
complete protease inhibitor. Crosslinked chromatin was sheared
into200–600bp fragments by sonication, clearedby centrifugation
at 15,0003 g for 15min, and stored at80C. A total of 20 mg chro-
matin supernatants were diluted (1:10) in ChIP buffer (200 mM
HEPES [pH 7.9], 2 M NaCl, and 20 mM EDTA) supplemented with
200 mg/ml salmon-spermDNAand complete protease inhibitor. Af-
ter preclearing the supernatants by rotating incubation for 30 min
at 4C with protein A–sepharose beads (Pierce), we stored half the
chromatin at 20C as the control chromatin input. The rest of
the supernatant was then incubated overnight at 4C with 20 ml
of Pax6 antibody (Covance) and cleared by centrifugation at
room temperature for 10 min at 80003 g before a 2 hr rotating in-
cubation at room temperature in 20 ml protein A-sepharose beads.
The beads were washed as follows: twice in ChIP buffer; twice in
ChIP buffer supplemented with 300 mM NaCl, 1% Triton X-100,
and 0.1% sodium deoxycholate; twice in Tris-HCl (pH 8.0), 250
mM LiCl, 2 mM EDTA, and 0.5% sodium deoxycholate; once in
10mMTris-HCl (pH 8.0), 1 mM EDTA, and 0.1%NP-40.We eluted
immune complexes by incubating them for 10 min at 65C in 111
mM Tris-HCl (pH 8.0) and 1.11% SDS. Crosslinks of the immuno-
precipitated DNA and the chromatin input were reversed by incu-
bation for 2hr at 42Cafter additionof20mg/mlProteinaseK (QIA-
GEN) and 100mMNaCl and further incubation overnight at 67C.
After extractionwithphenol-chloroform-isoamyl alcohol (25:24:1)
and chloroform-isoamyl alcohol (24:1), DNAwas precipitatedwith
100% ethanol in the presence of 20 mg glycogen (Fermentas) and 3
Msodiumacetate.Chromatinpelletswere resuspended in100ml TE
buffer. The immunoprecipitated DNA and the input chromatin
were analyzed by endpoint PCR (40 cycles) with TaqDNAPolymer-
ase in a Q-solution-supplemented buffer in accordance with the
manufacturer’s instructions (QIAGEN) and promoter- and exon2-
speciﬁc primers (Table S1). Design of the primers was performed ac-
cording to the Pax6 putative binding sites identiﬁed in silico in the
proximal region of the RFPL1,2,3 promoters with theMatInspector
server.
Comparative RFPL1,2,3 Gene-Expression Array
in Catarrhini
We used Affymetrix Human Exon 1.0 ST Arrays to measure gene-
expression proﬁles in ﬁve to six humans, ﬁve to six chimpanzees,
and two to four rhesus macaques from two age groups (adult and
newborn) and in three tissues (neocortex, cerebellum and liver).
All samples were sex and age matched to the best extent possible,
and all had high RNA-quality preservation. To identify the expres-
sion differences between the species, wemasked all probes that did
not match the three genomes perfectly, leading to the use of three
probes. Given the high homology of the three genes, we could not
however discriminate them. To determine whether the signal
intensity of a given probe was above the expected level of back-
ground noise, for each probe we compared its signal intensity to
a distribution of signal intensities of the ‘‘antigenomic’’ probes
with the same GC content provided by Affymetrix as an estimator
of the unspeciﬁc background hybridization. The probe signal
was classiﬁed as detected above the background if its intensity
was greater than the 95% percentile of the background probes
with the same GC content.24 To further remove the possible
systematic experimental differences among the arrays, we per-
formed a PM-GCBG correction and quantile normalization by
using ‘‘affy’’ R package. We calculated gene-expression intensities
as the means of all probe intensities mapped to the RFPL genes.
The ratios of expression levels were calculated within the species
and/or tissues.210 The American Journal of Human Genetics 83, 208–218, AugustGenetic Analyses
We created the alignment of RFPL gene family with ENCODE ge-
nome alignment (ENM 004)25 or by blasting human RFPL genes in
the UCSC genome browser. To reveal the structure of the family,
we ﬁrst determined the internal structure of the catarrhinian
RFPL1,2,3 subfamily. Given the loss of the ﬁrst exon of some genes
(Table S6), we created the sequence alignment including the genes’
intron and the second exon, which are present in all RFPL1,2,3 se-
quences. The tree was rooted with a macaque RFPL gene closest to
the RFPL1,2,3 cluster. We next created the coding sequence align-
ment including all RFPL1,2,3 genes found in the databases and the
best BLAST hits of hRFPL4,5,6 genes in Catarrhini. Out of 26 RFPL
genes, we selected a set of 21 most likely functional genes by using
the following criteria: standard gene structure (two coding exons),
start of CDS with a start codon, termination with a stop codon,
and no frameshift. ML phylogenetic analysis revealed the robust
monophyly of RFPL1,2,3 and RFPL4,5,6 primate-speciﬁc clades.
The phylogenetic reconstructions were performed by constraining
the topology of the clusters using the best BLAST hits. We then
rooted the topologywith the threeRFPL genes found inLaurasiathe-
ria and subsequently the bifurcation between the 21 likely func-
tional catarrhinian genes and the two genes found in Glires.
Estimations of KA/KS ratios (omegas) were made with CODEML
program implemented in PAML package with model 1 (Figure S1).
Assessment of selection acting on RFPL1,2,3 gene family in Catar-
rhini after the duplication events was performed with branch-site
model A (model ¼ 2, NSsites ¼ 2, ﬁx_omega ¼ 0; model ¼ 2 op-
tions allowing two omegas, one for the foreground clade and
the other for the rest of the tree). The null model was also
branch-site model A with omega for the foreground clade (Catar-
rhini RFPL1,2,3) ﬁxed to 1 (model¼ 2, NSsites¼ 2, ﬁx_omega¼ 1,
mega ¼ 1). We also applied the branch model for the same clade
(model¼ 2, NSsites¼ 0) with the null model speciﬁed bymodel¼ 0
and NSsites ¼ 0. We used a likelihood ratio test (LRT) to assess the
signiﬁcance of the difference between the two models. Positively
selected sites were estimated with the same method as well as
the M2 and M8 models, whereas M1 and M7 were used as the
null models respectively.
Statistical Analysis
Results are displayed as mean5 standard error (SEM) because the
criteria studied are all ratio levelmeasurements (i.e., continuous var-
iables). Analysis of the Pax6-elicited hRFPL1 and hRFPL2,3 expres-
sions byqPCRwasdonewith Student’s unpaired t test for twogroup
comparisons. Analyses of the hRFPL1, hRFPL2,3, and hRFPL4,5,6
expressions during neural differentiation of human embryonic
stem cells were performed by a one-way analysis of variance; this
was followed by post hoc multiple comparisons with Tukey test.
Analysis of correlations was performed with the Pearson product
moment correlation. Expression changes in catarrhinian RFPL1,2,3
genes were analyzed either by one-way ANOVA and then post
hocmultiple comparisonswithTukey test (intraspecies divergence)
or by Student’s t test (interspecies divergence). For all tests, a
p value that is less than 0.05 was taken as statistically signiﬁcant.
Results
Pax6 Elicits the Expression of the Human
RFPL1,2,3 Genes
Given the importance of cell-cycle regulation during corti-
cogenesis, we performed a microarray-expression analysis8, 2008
in Pax6-overexpressing HeLa cells, a reference human cell
system for cell-cycle study.
Pax6 overexpression resulted in marked changes in the
transcriptome (Table S6) and particularly modiﬁed the ex-
pression pattern of gene clusters involved in the control of
the cell cycle (Figure S2). The most striking change was ob-
served with the 800-fold increase in the human Ret Finger
Protein-Like 1 (hRFPL1) transcript level (Table S6), which
was also obtained with real-time PCR (Figure 1A). We
also observed a more moderate increase in hRFPL2 and
hRFPL3 gene expressions (Table S6 and Figure 1A). Given
the high homology between those two genes, we could
not however discriminate their individual expression by
real-time PCR. Putative Pax6 binding sites were predicted
in silico on each hRFPL1,2,3 promoters; chromatin-immu-
noprecipitation assay showed that Pax6 interacts in vivo
with all of these promoters (Figure 1B). Finally, we exam-
ined whether Pax6-induced transcriptional changes led
to hRFPL1,2,3 protein expression. Using a pan-hRFPL1,2,3
antibody, we observed hRFPL immunoﬂuorescence in
Pax6-expressing cells (Figure 1C). Taken together, those
Figure 1. Pax6 Interacts with the hRFPL1,2,3 Gene Promoters
and Induces Their Transcript and Protein Expressions
(A) hRFPL1 and hRFPL2,3 expressions were determined by real-time
PCR after overexpression of GFP or Pax6 in HeLa cells. Transcript
levels are indicated as the fold increase relative to the control level
(GFP-transduced cells). hRFPL2 and hRFPL3 are detected by a
common set of primers. Results are displayed as mean5 standard
error (SEM). Statistical analyses were done with Student’s t test,
**p < 0.01 and ***p < 0.001.
(B) In vivo binding of Pax6 to hRFPL1,2,3 promoters was assessed
by chromatin-immunoprecipitation assay. After chromatin immu-
noprecipitation with a Pax6 antibody, endpoint PCRs were per-
formed with primers specific for each hRFPL1,2,3 promoter or for
exon 2 of each gene for visualization of nonspecific immunoprecip-
itation. ‘‘Input’’ represents dilutions of input chromatin used as
PCR controls.
(C) Immunocytochemical detection of hRFPL1,2,3 proteins in GFP-
and Pax6-expressing HeLa cells with a pan-hRFPL1,2,3 antibody.
hRFPL1 overexpression was used as a control for antibody specificity.The Amdata suggest that Pax6 could induce hRFPL1,2,3 protein
expressions through direct promoter transactivation.
hRFPL1,2,3 Genes Are Expressed during Neurogenesis
In Vitro and In Vivo
We next examined hRFPL1,2,3 expression proﬁles during
neurogenesis in vitro and in vivo. During neural differenti-
ation of human embryonic stem cells, virtually no hRFPL1
and hRFPL,2,3 transcript levels were detected in NANOG-
positive human embryonic stem cells, nor in SIX3- and
SOX1-expressing neural precursors. Their expressions in-
creased signiﬁcantly at the onset of neurogenesis and
were correlated to those of the GABAergic neuronal
marker, GAD67 (Figure 2A).
hRFPL1 and hRFPL2,3 transcripts were also detected in
the developing human fetal brain. hRFPL1 transcripts
were highest in the temporal lobe, and hRFPL2,3 tran-
scripts were highest in the frontal lobe. All transcripts
were also detected in adult brain (Figure 2B).
Interestingly, a murine RFPL gene (mRFPL) was previ-
ously identiﬁed, but its expression had not been detected
in the mouse adult brain.26–28 Thus, we further compared
the expression proﬁle of mRFPL with that of hRFPL1,2,3
by PCR and did not detect any mRFPL transcript during
mouse embryonic stem cell-derived neurogenesis, during
in vitro maturation of primary cortical neurons, or in fetal,
newborn, and adult brains (Figure S3).
Identiﬁcation of the Likely Functional RFPL Genes
Given the absence of mRFPL brain expression, we investi-
gated at what point during evolution the RFPL genes
acquired brain expression by tracing their evolutionary
history. We ﬁrst searched for likely functional RFPL genes
by using the ENCODE TBA genomic alignments (ENM
004)25 and BLAT alignment in the UCSC genome browser.
They were found only in boreoeutherian mammals,
suggesting that the RFPL gene ancestor emerged ~100
mya (Table S2). Whereas one gene was identiﬁed in Laura-
siatheria (dog, cat, and horse) and Glires (mouse and rat),
multiple RFPL genes were found in Catarrhini (Great
Apes and Old World monkeys), including six in human.
Maximum-likelihood phylogenetic analysis showed that
the set of likely functional genes in Catarrhini formed
two isolated clusters: The ﬁrst one grouped the genes
orthologous to the human hRFPL1,2,3 genes, whereas
the second cluster grouped the genes orthologous to the
human hRFPL4,5,6 genes (Figure 3A).
The RFPL1,2,3 Genes Are Restricted to Catarrhini
In addition to those likely functional genes, we identiﬁed
in the marmoset genome a single degenerated RFPL1,2,3-
like sequence and nonfunctional RFPL4, RFPL5, and
RFPL6 genes (Table S2), indicating that the duplication of
the RFPL gene ancestor to generate the RFPL1,2,3 and
RFPL4,5,6 gene progenitors originated at least ~57 mya,
but after the Euarchonta-Glires split. Further, whereas the
intrachromosomal duplication of the RFPL4,5,6 geneerican Journal of Human Genetics 83, 208–218, August 8, 2008 211
Figure 2. hRFPL1,2,3 Genes Are Expressed during Human
Neurogenesis In Vitro and In Vivo
(A) hRFPL1 and hRFPL2,3 expressions were determined by real-time
PCR during human embryonic-stem-cells-derived neurogenesis and
normalized to the cDNA level in fetal brain. Results are displayed as
mean5 standard error (SEM). ***p < 0.001 versus day 0 with one-
wayANOVA followedbyposthoc Tukey’s test. hRFPL1andhRFPL2,3 ex-
pressions were correlated to those of the neuronal marker GAD67 (R2¼
0.99, p ¼ 0.003 for hRFPL1 versus GAD67; R2 ¼ 0.98, p ¼ 0.012 for
hRFPL2,3 versus GAD67 with Pearson product moment correlation).
(B) hRFPL1 and hRFPL2,3 expressions were assessed in different
structures of the developing brain and in adult neocortex by real-
time PCR normalized to the level of expression observed in adult
brain. The gender of the embryo (M, male; F, female) and its age
in weeks are indicated in the parentheses. Results are displayed as
mean5 standard error (SEM).212 The American Journal of Human Genetics 83, 208–218, Augustprogenitor was already present in marmoset, the lack of
multiple RFPL1,2,3-like sequences in New World monkey
suggested that the duplication of the RFPL1,2,3 gene
ancestor happened only in the Catarrhini lineage (~34
mya). This timing was supported by the calculation of pair-
wise Ks values among human, chimpanzee, and orangutan
paralogs; such Ks values were at least two times lower than
the average Ks divergence between human and marmoset
genomes29 (Table S3).
Not All RFPL1,2,3 Genes Are Functional in Catarrhini
Analysis of the topology of the RFPL1,2,3 clade with the
sequences of the intron and the second exon of each
gene showed that this subfamily forms three distinct clus-
ters corresponding to the RFPL1, RFPL2, and RFPL3 genes
(Figure 3B).
However, only human and orangutan, among the ge-
nomes available, kept the complete open reading frame
in the three RFPL1,2,3 genes. In contrast, some RFPL-
predicted polypeptides showed truncations (macaque
RFPL2 coding sequence has a frameshift leading to a stop
codon; chimpanzee RFPL1 50 region including exon 1
was inverted, which might lead to the synthesis of a trun-
cated protein only partially homologous to the other
RFPLs). Macaque RFPL1 and RFPL3 and baboon RFPL3
also lack an ORF after the loss of the ﬁrst exon (Table S2).
Figure 3. Topology of the RFPL Gene Family
(A) Phylogenetic tree based on RFPL coding sequences encoding
the likely functional proteins in Laurasiatheria, Glires, and Catar-
rhini. The RFPL1,2,3 clade shows a significant (p < 0.0001)
positive selection or constraint relaxation that is indicated by
the red box.
(B) ML phylogenetic tree of the catarrhinian RFPL1,2,3 genes. The
topology and branch lengths are based on concatenated align-
ments of the intron and the second exon. Branch lengths are scaled
to the number of substitutions per site. Bootstrap support values
are indicated at each node. Likely functional genes are shown in
green, truncated genes are shown in pink, and nonfunctional genes
are shown in gray. The following abbreviations are used in both
panels: h, human; c, chimpanzee; o, orangutan; b, baboon; ma,
macaque; and m, mouse.8, 2008
According to those results, Figure 4 illustrates the
presumptive timing of emergence and conservation of the
RFPL genes over the course of evolution.
Only the RFPL1,2,3 Gene Cluster Acquired Brain
Expression during Evolution
We then examined by real-time PCRwhether the RFPL4,5,6
gene cluster also acquired neural expression during evolu-
tion. Similarly to the absence of mRFPL expression in
mouse neural tissue,we didnot detect anyhRFPL4,5,6 tran-
scripts during human embryonic stem cell-derived neuro-
genesis or in human fetal and adult brains (Figure S4).
Thus, RFPL expression in neural tissue seemed to be
restricted to the catarrhinian-speciﬁc RFPL1,2,3 gene
cluster.
Cortical RFPL1,2,3 Gene Expression Increases in
Human in Comparison to Chimpanzee and Macaque
Several studies reported changes in gene expression in the
brain of human and other nonhuman primates, and these
ﬁndings seem to account for most phenotypic changes be-
tween those species.8,9 We therefore investigated whether
RFPL1,2,3 genes had different cerebral expression levels
among humans, chimpanzees, and macaques and deter-
mined RFPL1,2,3 gene-expression proﬁles in newborn
and adult neocortex, cerebellum, and liver by using data
from microarray transcriptome studies.
First, this approach showed that RFPL1,2,3 expressions
in newborn and adult brains were also detected in chim-
panzees and macaques, indicating that those genes can
also exert a role in brain development and function in
other Catarrhini. Second, intraspecies comparisons of
RFPL1,2,3 expressions in different tissues pointed out
Figure 4. Timing of the Emergence of
the RFPL Genes during Evolution
The RFPL gene ancestor is shown in black.
Each likely functional RFPL1, RFPL2, and
RFPL3 gene is indicated in green, truncated
genes are indicated in pink, and genes with
no ORF are indicated in gray. Putative
baboon RFPL1 gene is indicated in a dashed
line. The RFPL4,5,6 gene cluster is repre-
sented by a single purple line. The estimated
time of the gene-ancestor emergence and
subsequent duplication events are indicated
in millions of years (mya).
a change directed toward brain ex-
pression of the RFPL1,2,3 genes
through evolution. This was particu-
larly marked in humans in which
RFPL1,2,3 transcript levels signiﬁ-
cantly increased in newborn and
adult neocortex and cerebellum in
comparison to the liver, used as a non-
neural, RFPL1,2,3-expressing control
tissue (Figure 5A). Furthermore, we observed in humans
that RFPL1,2,3 transcript levels in the neocortex were
higher than in the cerebellum, both in newborn and adult
tissues (Figure 5A). However, this divergence was not ob-
served in chimpanzees and macaques, suggesting that
the adaptation of RFPL1,2,3 toward cortical expression is
speciﬁc to human (Figure 5A). This was conﬁrmed by inter-
species comparisons that showed that cortical RFPL1,2,3
transcript levels were signiﬁcantly higher in humans
than in chimpanzees or macaques, whereas only marginal
interspecies differences were observed in the cerebellum
(Figure 5B), and none was seen in the liver (data not
shown).
Positive Selection Acted on the RFPL1,2,3 Genes
We next examined the evolutionary forces that acted
on the RFPL1,2,3 coding sequences to determine the
RFPL1,2,3 protein evolution. First, we analyzed the struc-
ture of the RFPL proteins in silico to examine the acquisi-
tion of neofunctionalization (Figure 6). All RFPL proteins
shared a RING domain and a B30.2 domain composed of
the PRY and SPRY motifs. In addition, we identiﬁed a pro-
tein motif (Pfam B-20538) bridging those RING and B30.2
domains. Using BLAST search, we found that this domain
was present in all RFPLs but was exclusively restricted to
those proteins. We referred this ﬁrst sign of neofunctional-
ization to as RFPL-deﬁning motif (RDM; Figure 6). We
found a second neofunctionalization event with the ap-
pearance of an upstream translational initiation site only
in the catarrhinian RFPL1,2,3 genes (except for chimpan-
zee and orangutan RFPL3). This would lead to a predicted
synthesis of 29 additional amino acids on N-terminus (Fig-
ure 6). No putative protein domain could be deﬁned from
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the different analyses we performed. Nonetheless, second-
ary structure predictions indicated that this sequence con-
tained a hydrophobic region potentially forming an alpha
helix loop that we termed RFPL1,2,3-specifying helix
(RSH). No other protein that contained the complete 29
amino acid sequence or RSH could be identiﬁed.
Second, we investigated whether the RFPL1,2,3 genes
evolved under positive selection by using the previously
described topology (Figure 3A). We tested the a priori hy-
pothesis that positive selection occurred after the duplica-
tions that led to the generation of the brain-expressed
RFPL1,2,3 cluster because selective pressure is often ob-
served after duplication events to retain the functionality
of the daughter genes.30 The ratio of nonsynonymous
(KA) over synonymous (KS) substitutions per site in RFPL
genes was 0.53 on average, indicating that the whole
family was under strong purifying selection. However, we
observed a signiﬁcant increase of nonsynonymous substi-
tutions in the RFPL1,2,3 cluster (KA/KS ¼ 0.73), with both
Figure 5. Expression Divergence between Human, Chimpanzee
and Macaque RFPL1,2,3 Genes in Brain
RFPL1,2,3 gene expressions were assessed in newborn and adult
neocortex, cerebellum, and liver by microarray transcriptome stud-
ies in humans, chimpanzees, and macaques. Results are displayed
as mean 5 standard error (SEM). The following abbreviations are
used: Cx, neocortex; Cb, cerebellum; Liv, liver; H, human; C, chim-
panzee; and Ma, macaque. (A) shows intraspecies divergence in
RFPL1,2,3 tissue expression. Cortical and cerebellar RFPL1,2,3 tran-
script levels were normalized to that of the liver. *p < 0.05, **p <
0.01, and ***p < 0.001 for neocortex or cerebellum versus liver;
#p < 0.05 and ##p < 0.01 for neocortex versus cerebellum with one-
way ANOVA followed by post hoc Tukey test. (B) shows interspecies
divergence in cortical and cerebellar RFPL1,2,3 expression levels.
hRFPL1,2,3 expressions were normalized to those in chimpanzee
or macaque. *p < 0.05 and ***p < 0.001 with Student’s t test.214 The American Journal of Human Genetics 83, 208–218, Augustbranch-site and branch models, suggesting an accelerated
protein evolution driven by positive selection or a relaxa-
tion of constraints (Figure 3A).
Positive selection was highly variable across sites in
RFPL1,2,3 genes. Estimates of KA/KS under models that
allow for positive selection indicated that a fraction of sites
(6.6% to 9.8%) evolved under positive selection (Table S4).
The amino acid changes that occurred at sites inferred to
have been under positive selection in RFPL1,2,3 proteins
in Catarrhini were mainly located in the B30.2 domain
(Table S5).
Discussion
Understanding the genetic basis of human brain evolution
remains a major challenge in neuroscience. Here we iden-
tiﬁed the human RFPL1,2,3 genes (MIM 605968, 605969,
and 605970) as Pax6 targets and showed that they are
highly expressed at the onset of neurogenesis during neu-
ral differentiation of human embryonic stem cells. Expres-
sion of hRFPL1,2,3 was also detected in vivo in human
developing brain, and the highest levels were found in
the temporal and frontal cortical lobes, which have been
previously described to be developmentally inﬂuenced by
Pax6.19 Given the similarity in the structure of all RFPLs
and the interaction of mRFPL with cyclin B1,27 hRFPL1,2,3
could therefore affect cell-cycle parameters and exert a role
in Pax6-dependent generation of cortical cells. Further, the
present genetic analysis shows that the hRFPL1,2,3 gene
evolution exhibits the same features as those observed at
the genome-wide level in the hominoid lineage, namely
Figure 6. RFPL-Protein-Domain Predictions Reveal the Acqui-
sition of RDM and RSH as Neofunctionalization Events
Identification of RFPL-specific RDM (RFPL-defining motif) and RSH
(RFPL1,2,3-specifying helix) were obtained after the alignment of
the likely functional catarrhinian RFPL1,2,3 and murine mRFPL pro-
teins and in silico predictions of secondary structures and protein
domains. The following abbreviations are used: h, human; c, chim-
panzee; o, orangutan; b, baboon; ma, macaque; and m: mouse.8, 2008
an expansion in gene copy number, an increase in cortical
expression, and an acceleration in protein evolution.
First, we observed that the RFPL gene family emerged re-
cently in evolutionary terms and expanded during evo-
lution after duplication events. However, only the
RFPL1,2,3 gene cluster acquired brain expression during
this period. The RFPL1,2,3 progenitor gene emerged after
the Euarchonta-Glires split. Subsequently, intrachromoso-
mal segmental duplications occurred in Catarrhini to gen-
erate the RFPL1,2,3 gene cluster ~34 mya. Yet, the mainte-
nance of the functionality of the three RFPL1,2,3 genes was
not ensured in Old World monkeys because of degenera-
tion of some gene duplicates. Thus, an increase in
RFPL1,2,3 gene copy number occurred in the hominoid
lineage; this is in accordance with the increase in gene
copy number previously observed at the genome-wide
level in the hominoid lineage with interspecies cDNA
or BAC array-based comparative genomic hybridiza-
tion.7,31,32 Interestingly, those changes were particularly
pronounced in genes with a role in brain development
and function.7 The regions enriched in copy-number vari-
ations have been found to be not randomly distributed
in the genome but are preferentially present in regions
thought to be genomically and evolutionary dynamic.
This is particularly the case for the 22q11-q13 region,7,31
which corresponds to the chromosomal location of the
hRFPL1,2,3 gene cluster (22q12.2-q12.3).
Second, changes in transcript levels of the neocortex
have been reported in several comparative studies between
human and other primates.8,33–35 Those changes were pre-
dominantly directed toward an increase in mRNA levels in
human,9 suggesting that constraints imposed by gene-dos-
age requirements are a major mechanism for the extensive
modiﬁcations of brain development and physiology
during primate evolution. Fitting with this concept, we
observed an increase in brain RFPL1,2,3 transcript level
in humans, both in newborn and adult tissues, in compar-
ison to chimpanzees and macaques. Such a divergence was
dramatic in the neocortex. However, the fact that the
number of likely functional RFPL1,2,3 genes in Catarrhini
(human ¼ orangutan R chimpanzee > macaque) is not
correlated with their neocortex expression level (human >
macaque > chimpanzee) or with neocortex evolution in
size (human > chimpanzee z orangutan > macaque)
suggests that the increase in RFPL1,2,3 transcript level
can not be fully explained by the increase in gene copy
number in the hominoid lineage. Hence, mutations in
the regulatory sequences of those genes during evolution
could have led to distinct transcriptional regulation of
RFPL1,2,3 expression in the developing neocortex of those
different species. Remarkably, human is the only catarrhi-
nian species among the three studied to have a RFPL1,2,3
expression signiﬁcantly higher in the neocortex than in
the cerebellum, suggesting that the RFPL1,2,3 gene expres-
sion was selectively directed toward the neocortex in the
human lineage. In addition, the inﬂuence of posttranscrip-
tional regulatory mechanisms could also be essential.The AmIndeed, noncoding mRNAs of hRFPL1S (MIM 605972)
and hRFPL3S (MIM 605971) antisense genes covering large
portions of the sense hRFPL1 and hRFPL3 genes have been
detected.36 In addition, the study of the human chromo-
some 22 revealed the presence of two hRFPL pseudogenes
(hRFPLc1 and hRFPLc2).36 It has been shown that pseudo-
genes can still play important functional roles, notably by
controlling, as antisense sequences, the stability of the
messenger RNA of their homologous coding sequences.37
Therefore, the hRFPL pseudogene copies may not be neces-
sarily functionally silent; such a ﬁnding could also be
important for the evolutionary differences in RFPL1,2,3
expression proﬁles between Catarrhini.
Third, we found an acceleration in the evolution of the
RFPL proteins. Neofunctionalization events, considered as
signs of positive selection, are usually acquired to retain
the functionality of the duplicate genes during evolution
by providing them a new function.30 In this line, the pro-
tein domains found in RFPLs appeared at different times
of evolution and as such corroborates our estimated period
of emergence of the RFPL gene ancestor. Whereas SPRY
appeared in eukaryotes, PRY is limited to vertebrates in
which it associated with SPRY to form the B30.2 domain.
The acquisition of the RING-type zinc-ﬁnger domain in
B30.2-containing proteins appeared later and led to the
generation of the TRIM protein family that is restricted to
primates, rodents, and Xenopus.38 Here, we reported the
emergence of RFPL-speciﬁc neofunctionalization events.
One of these events was the acquisition of the RFPL-deﬁn-
ing motif possibly after the gene-duplication event that
led to the emergence of the RFPL gene ancestor. A second
sign of neofunctionalization consisted of the appearance
of anupstreamtranscriptional initiation site in catarrhinian
RFPL1,2,3genes.Moreover, analysis of positive selection in-
dicated that the RFPL1,2,3 cluster showed an accelerated
evolution. This was particularly notable after the duplica-
tion events that led to the emergence of the RFPL1 (KA/KS¼
1.1) and RFPL2 (KA/KS ¼ 1.0) genes. The observed positive
selection is quantitatively moderate, and one could argue
that it only reﬂects a relaxation of constraints. However,
the different events we underlined above (gene duplication
and retention, acquisition of brain expression, and emer-
gence of new domains) are in favor of positive selection.
We observed that the positive selection mainly affected
the B30.2 domain, and this is accordance with the selective
pressure observed in this domain in the human lineage of
other TRIM proteins in order to provide speciﬁcity to their
protein-protein interactions.39–42 Indeed, the amino acids
lining the binding surface of the B30.2 domain are highly
variable, and it was suggested that B30.2 is a protein-inter-
acting module recognizing speciﬁc partners rather than
a consensus sequencemotif.39,41Moreover, binding studies
withmRFPL indicated that itsproteinpartnerswerebinding
to the B30.2 domain.27 Therefore, the positive selection on
the B30.2 domain in the RFPL1,2,3 cluster may have pro-
vided the acquisition of new partners and/or more selectiv-
ity toward those identiﬁed with mRFPL.erican Journal of Human Genetics 83, 208–218, August 8, 2008 215
Only a few speciﬁc genes with an impact on brain evo-
lution and/or development have been identiﬁed so far;
these are the MCPH genes (determining brain size), FoxP2
(involved in speech production [MIM 605317]), GLUD2
(a brain-speciﬁc glutamate dehydrogenase important for
glutamate detoxiﬁcation after neuron ﬁring [MIM 300144])
and HAR1 (coexpressed with reelin in Cajal-Retzius cells in
human developing brain [MIM 610556]).43–46 The late
emergence of the RFPL1,2,3 gene cluster in Catarrhini is
similar only to that of GLUD2, which appeared between
~18 and 23 mya after the hominoid-Old World monkey
separation.45 However, all those genes have in common
a period of accelerated protein evolution that coincides
together, as well as with a period of increased structural
and functional complexity at the cerebral level.11–13,45–47
The increase in RFPL1,2,3 gene expression in the human
neocortex is also in accordance with the importance of
gene-dosage constraints reported with FoxP2 in human.44
Thus, RFPL1,2,3 duplications to generate a brain-expressed
cluster could be an important feature for human brain de-
velopment and evolution. This could be corroborated by
the recent ﬁnding that a 1:22 chromosomal translocation
in the q12.1-q12.3 region, where the hRFPL1,2,3 gene clus-
ter is located, has been observed in patients suffering from
theCostello syndrome,48 a disease showingmental retarda-
tion and multiple brain atrophies49 (MIM 218040).
The impact of theRFPL1,2,3 genes onneocortex develop-
ment remains to be determined. Given their presumptive
role on cell-cycle regulation,27 one could establish parallels
with other cell-cycle-progression mediators, such as p27
Kip1 or the MCPH genes, and hypothesize that RFPL1,2,3
genes may similarly control the balance between prolifera-
tive and neurogenic divisions and thereby the number of
cortical cells generated. Hence, the RFPL1,2,3 genes could
alter the patterning of speciﬁc neocortical areas like the cy-
clin E-regulating p27Kip1, whose differential expression in
areas 17 and 18 of the neocortex affects neuron production
that contributes todistinct areal cytoarchitectonics.50Alter-
natively, the RFPL1,2,3 genes could affect brain morphol-
ogy and size determination, like the MCPH1-6 genes.
Indeed, those genes control the type of cell division (prolif-
erative versus neurogenic) by regulating mitotic-spindle
orientation or centrosome assembly,3,51 and their muta-
tions were shown to be responsible for primarymicroceph-
aly, a disorder characterized by a reduction inneocortex size
due to a decrease in neuron production.51
In conclusion, our observations suggest that the recent
emergence and multiplication of the RFPL1,2,3 genes
may be important for brain development and function in
Catarrhini. Their role could be even more essential in hu-
mans because this species maintained the complete open
reading frames in all three genes and shows a striking
increase in cortical RFPL1,2,3 expressions in comparison
to chimpanzees and macaques. We therefore propose
that the RFPL1,2,3 genes may contribute to changes in
cortical organization leading to the acquisition of human-
speciﬁc behavioral traits.216 The American Journal of Human Genetics 83, 208–218, August 8Supplemental Data
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